Inovio Pharmaceuticals
INO
INO
76 hedge funds and large institutions have $125M invested in Inovio Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 26
3% less funds holding
Funds holding: 78 → 76 (-2)
65% less call options, than puts
Call options by funds: $6.02M | Put options by funds: $17.4M
Holders
76
Holding in Top 10
1
Calls
$6.02M
Puts
$17.4M
Top Buyers
| 1 | +$16M | |
| 2 | +$10.9M | |
| 3 | +$6.86M | |
| 4 |
Morgan Stanley
New York
|
+$4.7M |
| 5 |
Goldman Sachs
New York
|
+$4.6M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$9.24M | |
| 3 | -$4.16M | |
| 4 |
BC
Broadfin Capital
New York
|
-$4.16M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.22M |